Codjwill: Created page with " ==BackgroundSanford Guide to Antimicrobial Therapy 2025== Gram variable coccobacilli implicated as a factor in bacterial vaginosis Facultative anaerobe Non-spore forming ==Clinical FeaturesSanford Guide to Antimicrobial Therapy 2025== See '''bacterial vaginosis''' Spectrum of asymptomatic to malodorous whitish-gray vaginal discharge Clue cells with bacteria on surface of vaginal epithelial cells on wet..."

2026-03-13T02:29:12Z

Created page with " <translate> ==Background<ref>Sanford Guide to Antimicrobial Therapy 2025</ref>==  *Gram variable coccobacilli implicated as a factor in bacterial vaginosis *Facultative anaerobe *Non-spore forming ==Clinical Features<ref>Sanford Guide to Antimicrobial Therapy 2025</ref>== *See '''bacterial vaginosis''' **Spectrum of asymptomatic to malodorous whitish-gray vaginal discharge **Clue cells with bacteria on surface of vaginal epithelial cells on wet..."

New page

<translate>

==Background<ref>Sanford Guide to Antimicrobial Therapy 2025</ref>== 
*[[Gram variable]] coccobacilli implicated as a factor in [[bacterial vaginosis]]
*Facultative anaerobe
*Non-spore forming

==Clinical Features<ref>Sanford Guide to Antimicrobial Therapy 2025</ref>==
*See '''[[bacterial vaginosis]]'''
**Spectrum of asymptomatic to malodorous whitish-gray vaginal discharge
**Clue cells with bacteria on surface of vaginal epithelial cells on wet mount
**Bacterial vaginosis is a multi-organism dysbiosis
***''G. vaginalis'' can be isolated in healthy vaginal microbiome but is not the dominant species

==[[Special:MyLanguage/Antibiotic Sensitivities|Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== 


{| class="wikitable"

*'''Please reference your updated local antibiogram'''
*Primary Regimens:<ref>Sanford Guide to Antimicrobial Therapy 2025</ref>
**Metronidazole 500 mg PO BID x7 days
***Single dose metronidazole no longer recommended
**Metronidazole 0.75% gel one applicator (5 g) intravaginally daily x5 days
**Clindamycin 2% vaginal cream one applicator (5 g) intravaginally nightly x7 days
**Clindamycin 300 mg PO BID x7 days

===Key=== 

</translate>
{{Antibacterial Spectra Key}}
<translate>

==Table Overview== 

</translate>
{{Clinically Relevant Bacteria}}
<translate>

==See Also== 


*[[Special:MyLanguage/Microbiology (Main)|Microbiology (Main)]]

==References== 


<references/>


[[Category:ID]]
</translate>

Gardnerella - Revision history